Please Wait.....
Report
Oxygen Therapy Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 114 Pages I Mordor Intelligence
Oxygen Therapy Equipment Market Analysis
The oxygen therapy equipment market generated USD 3.85 billion in 2025 and is forecast to reach USD 5.32 billion by 2030, advancing at a 6.85% CAGR. Growth is propelled by the rising global burden of chronic respiratory diseases, rapid device miniaturization, sustained investment in home healthcare, and supportive reimbursement frameworks. Intensifying product recalls and exits by prominent manufacturers are widening supply gaps that agile competitors are filling, while IoT-enabled monitoring is redefining care pathways across acute and chronic settings. At the same time, evolving regulatory regimes and component-level supply chain vulnerabilities are shaping competitive strategies and capital allocation priorities. Heightened clinical demand for portable concentrators, telehealth integration, and advanced battery chemistries underscores the market's pivot toward patient-centric, data-driven respiratory care solutions.
Global Oxygen Therapy Equipment Market Trends and Insights
Rising COPD & Other Respiratory Disease Prevalence
The escalating incidence of COPD, asthma, and interstitial lung diseases is a critical demand driver for the oxygen therapy equipment market. Nearly 90% of COPD-related deaths occur in low- and middle-income countries, underscoring unmet therapeutic needs . Environmental pollution accounts for 41.79% of COPD risk factors among younger cohorts, while smoking contributes 19.81%, indicating structural demand independent of tobacco trends. As global populations age, prevalence rises in tandem, particularly across Asia-Pacific economies experiencing rapid demographic shifts.
Shift Toward Home-Based Oxygen Therapy & Portable Devices
Cost-containment imperatives and patient preference for independence are accelerating the transition from facility-based to home-based therapy. US home healthcare expenditures for 3 million Medicare beneficiaries totaled USD 125.2 billion in 2024. The Home Health Value-Based Purchasing Model now links payments to quality outcomes, stimulating adoption of connected portable concentrators that support real-time monitoring. Inogen's Rove 4-which delivers 840 ml/min oxygen at under 1.36 kg-exemplifies how design advances eliminate mobility barriers.
Stringent Global Regulatory Approvals & Compliance Costs
The European Union Medical Device Regulation (EU 2017/745) mandates broader clinical evidence, post-market surveillance, and Unique Device Identification by 2027-2028, materially escalating compliance spending . Smaller manufacturers face disproportionate burdens, potentially hastening consolidation. In the United States, the FDA's updated medical gas regulations effective December 2025 revise CGMP standards and safety reporting obligations, adding documentation layers for oxygen suppliers .
Other drivers and restraints analyzed in the detailed report include:
Rapid Device Miniaturization & IoT-Enabled Monitoring / Next-Gen Lithium-Sulfur Batteries Enabling Ultra-Light POCs / High Capital/Reimbursement Burden for Long-Term Therapy /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Oxygen Source Equipment held 65.35% of the oxygen therapy equipment market share in 2024. Concentrators drive this segment through pressure-swing adsorption efficiency gains, while liquid systems cater to high-purity therapeutic niches. Compressed cylinders remain vital for emergency back-up, particularly in EMS fleets. The oxygen therapy equipment market size for delivery devices is refining at a 7.25% CAGR, fueled by patient comfort innovations such as Fisher & Paykel's F&P Nova Nasal mask with integrated humidity control. Smart cannulas fitted with saturation sensors relay adherence data, improving regulatory compliance with emerging quality-of-life metrics.
Supporting this shift, concentric supply disruptions-most notably Philips Respironics' 2024 discontinuation of 19 respiratory SKUs-have encouraged hospitals and distributors to dual-source delivery interfaces. Rapid regulatory approvals for alternative interfaces accelerated portfolio diversification. Digital fit-testing, 3-D-printed adapter options, and antimicrobial tubing coatings have entered mainstream procurement discussions across US hospital groups.
Stationary concentrators still captured 53.82% of the oxygen therapy equipment market size in 2024 even as consumer discourse focuses on portability. Reliability and continuous high-flow capabilities suit severe hypoxemic COPD patients, and payers often reimburse these devices preferentially under capped rental models. Recent releases like Caire's IntenOxy 5 deliver 95.5% purity at 5 LPM while drawing under 330 W, reducing electricity costs for seniors on fixed incomes. Manufacturers also add smart-grid interfaces to balance residential power loads and claim sustainability credits.
Portable devices account for the remaining share but post the market's fastest absolute revenue gains. The oxygen therapy equipment market demonstrates 8.9% CAGR for ultra-portable devices as battery energy densities climb, extending run-time beyond 6 hours at pulse setting 3. Companies are bundling service subscription models that cover consumables, firmware upgrades, and telemonitoring analytics. Integrators experiment with modular ecosystems pairing a bedside station with a backpack-size concentrator using interchangeable sieve cartridges, ensuring continuity during travel or outages.
The Report Covers Global Oxygen Therapy Device Market Share and Size. The Market is Segmented by Product (Oxygen Source Equipment and More), Portability (Stationary Devices and Portable Devices), Application (Asthma, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disorder (COPD), and More), End User (Hospitals and Home Healthcare) and Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America generated 43.62% of 2024 revenue, supported by robust reimbursement systems, high COPD prevalence, and mature distribution networks. The FDA's December 2025 medical gas mandate intensifies audit preparation among US manufacturers, while Canada's federal-provincial drug plans continue to integrate portable concentrator benefits. Mexico's Seguro Popular expansion drives localized assembly partnerships to reduce import duties.
Asia-Pacific is the fastest-growing territory, posting 9.14% CAGR thanks to healthcare spending growth, universal insurance rollouts, and aging demographics. China's medical device market is projected to reach USD 138 billion by 2027. Though COPD prevalence is stabilizing, absolute patient volumes remain huge. India witnesses double-digit demand growth as public-private partnerships upgrade district hospitals with oxygen plants. Japanese and South Korean suppliers leverage domestic R&D to export connected concentrators across ASEAN markets, while Australian telehealth frameworks accelerate cross-border RPM adoption.
Europe maintains steady growth underpinned by MDR-compliant product refresh cycles and aging populations. Germany's sickness funds reimburse portable concentrators when paired with adherence-monitoring apps, boosting smart device uptake. The United Kingdom's NHS Community Oxygen Service deploys remote titration pilots aimed at reducing clinic visits. Southern European economies align procurement criteria with EU medical gas standards, expanding opportunities for value-focused vendors.
The Middle East & Africa region records double-digit growth from a low base as governments establish pressure swing adsorption plants following COVID-19 shortages. MedAccess and development banks finance manufacturing hubs to localize sieve production, enhancing regional self-sufficiency. Latin America's trajectory is mixed: Brazil's Unified Health System rolls out oxygen concentrators to secondary hospitals, yet currency volatility challenges importer margins in Argentina and Colombia.
List of Companies Covered in this Report:
Koninklijke Philips / Caire / Invacare / Drive DeVilbiss Healthcare / Resmed / Fisher & Paykel Healthcare / Teleflex / Smiths Group / Linde Healthcare / Dragerwerk / Chart Industries (AirSep) / Inogen Inc. / Nidek Medical Products / Air Liquide / Allied Healthcare Products / GCE Group / Hersill S.L. / TECNO-GAZ / OxyGo LLC / BPL / Precision Medical / Besco Medical /
Additional Benefits:
- The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising COPD & Other Respiratory Disease Prevalence
4.2.2 Shift Toward Home-Based Oxygen Therapy & Portable Devices
4.2.3 Rapid Device Miniaturisation & Iot-Enabled Monitoring
4.2.4 Next-Gen Lithium-Sulfur Batteries Enabling Ultra-Light Pocs
4.2.5 Stricter Hospital Accreditation Standards
4.2.6 Telehealth-Integrated Remote Oxygen Management Demand
4.3 Market Restraints
4.3.1 Stringent Global Regulatory Approvals & Compliance Costs
4.3.2 High Capital/Reimbursement Burden For Long-Term Therapy
4.3.3 Supply-Chain Fragility Of Zeolite Molecular-Sieves
4.3.4 Rising Fire-Safety & Insurance Restrictions In Home Use
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Product
5.1.1 Oxygen Source Equipment
5.1.1.1 Oxygen Cylinders
5.1.1.2 Oxygen Concentrators
5.1.1.3 Liquid Oxygen Devices
5.1.1.4 Others
5.1.2 Oxygen Delivery Devices
5.1.2.1 Oxygen Masks
5.1.2.2 Nasal Cannula
5.1.2.3 Venturi Masks
5.1.2.4 Non-Rebreather Masks
5.1.2.5 Others
5.2 By Portability
5.2.1 Stationary Devices
5.2.2 Portable Devices
5.3 By Application
5.3.1 Asthma
5.3.2 Obstructive Sleep Apnea
5.3.3 Chronic Obstructive Pulmonary Disease (COPD)
5.3.4 Respiratory Distress Syndrome
5.3.5 Others
5.4 By End User
5.4.1 Hospitals
5.4.2 Home Healthcare
5.4.3 Ambulatory Surgical Centers
5.4.4 Others
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Koninklijke Philips N.V.
6.3.2 CAIRE Inc.
6.3.3 Invacare Corporation
6.3.4 Drive DeVilbiss Healthcare
6.3.5 ResMed
6.3.6 Fisher & Paykel Healthcare
6.3.7 Teleflex Incorporated
6.3.8 Smiths Medical
6.3.9 Linde Healthcare
6.3.10 Dragerwerk AG & Co. KGaA
6.3.11 Chart Industries (AirSep)
6.3.12 Inogen Inc.
6.3.13 Nidek Medical Products
6.3.14 Air Liquide Healthcare
6.3.15 Allied Healthcare Products
6.3.16 GCE Group
6.3.17 Hersill S.L.
6.3.18 TECNO-GAZ SpA
6.3.19 OxyGo LLC
6.3.20 BPL Medical Technologies
6.3.21 Precision Medical Inc.
6.3.22 Besco Medical
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security